On March 9, 2015, a reply to objections and responses filed with respect to the motion for authority to take discovery was filed in the bankruptcy case of Natrol, Inc. and its affiliates.
The filing was assigned docket number 962 and is described on the court’s official docket as follows:
Motion for Leave Plethico Pharmaceuticals Limiteds Motion (I) for Permission to File a Reply to Response of GLC Advisors & Co., LLC to Plethico Pharmaceuticals Limiteds Objection to the Third and Final Fee Application of GLC Advisors & Co., LLC, and (II) Requesting That March 11, 2015 Hearing on These Matters Be a Status Conference and Requesting Time to Conduct Discovery (related document(s), , ) Filed by Plethico Pharmaceuticals Limited and its affiliates. (Attachments: # (1) Proposed Form of Order # (2) Certificate of Service) (Bifferato, Karen)
Natrol, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on June 11, 2014. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 14-11446. The bankruptcy case is currently assigned to United States Bankruptcy Judge Brendan Linehan Shannon. The law firm of Gibson Dunn & Crutcher LLP is acting as lead bankruptcy counsel to Natrol, Inc. in the bankruptcy case.